Structural visualizations illuminate remdesivir's mechanism of action

May 01, 2020

In a new study, researchers report the structure of remdesivir - an antiviral drug that has shown promise against the SARS-CoV-2 virus in lab studies and early clinical trials - bound to both a molecule of RNA and to the viral polymerase. The new structural information illuminates the mechanism that remdesivir uses to interrupt RNA replication and shut down viral reproduction - and may inform efforts to develop new and more potent therapies that employ a similar mechanism. As the enzyme that catalyzes the synthesis of viral RNA for SARS-CoV-2, thus playing a central role in its replication, the polymerase is a primary target for fighting the virus. Prior work had reported the structure of the polymerase - an RNA-dependent RNA polymerase - using cryo-electron microscopy (cryo-EM). Wanchao Yin and colleagues took this further by again imaging the polymerase, which consists of four subunits - nsp12, nsp7, and two units of nsp8 - using cryo-EM at 2.8 angstrom resolution, obtaining results consistent with the previously determined structure. They then imaged a complex of the polymerase bound to both an RNA template and to a molecule of remdesivir, using cryo-EM at 2.5 angstrom resolution. In its active form, remdesivir mimics the structure of adenosine, a nucleoside that is incorporated into RNA during replication. When the drug, instead of a nucleoside, is added to a new RNA molecule it blocks further synthesis of viral RNA. The detailed cryo-EM structural information enabled Yin et al. to pinpoint the precise residues of the polymerase that interact with both the RNA template and remdesivir. These insights, in turn, will inform efforts to design more effective therapies that also mimic nucleosides to disrupt viral replication, and may lead to better understanding of existing nucleoside mimic drugs such as EIDD-2801, ribavirin, galidesivir, and favipiravir, the authors suggest.

American Association for the Advancement of Science

Related RNA Articles from Brightsurf:

A new RNA catalyst from the lab
On the track of evolution: a catalytically active RNA molecule that specifically attaches methyl groups to other RNAs - a research group from the University of Würzburg reports on this new discovery in Nature.

Small RNA as a central player in infections
The most important pathogenicity factors of the gastric pathogen Helicobacter pylori are centrally regulated by a small RNA molecule, NikS.

RNA as a future cure for hereditary diseases
ETH Zurich scientists have developed an RNA molecule that can be used in bone marrow cells to correct genetic errors that affect protein production.

Bringing RNA into genomics
By studying RNA-binding proteins, a research consortium known as ENCODE (Encyclopedia of DNA Elements) has identified genomic sites that appear to code for RNA molecules that influence gene expression.

RNA key in helping stem cells know what to become
If every cell has the same genetic blueprint, why does an eye cell look and act so differently than a brain cell or skin cell?

RNA structures by the thousands
Researchers from Bochum and Münster have developed a new method to determine the structures of all RNA molecules in a bacterial cell at once.

New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus
Researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center and New York University have developed a new kind of CRISPR screen technology to target RNA.

Discovery of entirely new class of RNA caps in bacteria
The group of Dr. Hana Cahová of the Institute of Organic Chemistry and Biochemistry of the CAS, in collaboration with scientists from the Institute of Microbiology of the CAS, has discovered an entirely new class of dinucleoside polyphosphate 5'RNA caps in bacteria and described the function of alarmones and their mechanism of function.

New RNA mapping technique shows how RNA interacts with chromatin in the genome
A group led by scientists from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a new method, RADICL-seq, which allows scientists to better understand how RNA interacts with the genome through chromatin--the structure in which the genome is organized.

Characterising RNA alterations in cancer
The largest and most comprehensive catalogue of cancer-specific RNA alterations reveals new insights into the cancer genome.

Read More: RNA News and RNA Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to